Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Opko Health Inc (OPK)

Opko Health Inc (OPK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 834,974
  • Shares Outstanding, K 759,067
  • Annual Sales, $ 606,880 K
  • Annual Income, $ -225,680 K
  • EBIT $ -40 M
  • EBITDA $ 57 M
  • 60-Month Beta 1.50
  • Price/Sales 1.40
  • Price/Cash Flow N/A
  • Price/Book 0.67

Options Overview Details

View History
  • Implied Volatility 411.49% (-83.01%)
  • Historical Volatility 39.06%
  • IV Percentile 97%
  • IV Rank 54.23%
  • IV High 713.69% on 03/11/26
  • IV Low 53.43% on 08/22/25
  • Expected Move (DTE 17) 0.2380 (20.88%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 200
  • Volume Avg (30-Day) 383
  • Put/Call OI Ratio 0.06
  • Today's Open Interest 26,892
  • Open Int (30-Day) 28,797
  • Expected Range 0.9020 to 1.3780

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate -0.07
  • Number of Estimates 5
  • High Estimate -0.05
  • Low Estimate -0.08
  • Prior Year -0.10
  • Growth Rate Est. (year over year) +30.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0950 +4.11%
on 03/30/26
1.2500 -8.80%
on 03/02/26
-0.0600 (-5.00%)
since 02/27/26
3-Month
1.0950 +4.11%
on 03/30/26
1.4300 -20.28%
on 01/22/26
-0.1500 (-11.63%)
since 12/26/25
52-Week
1.0950 +4.11%
on 03/30/26
1.6900 -32.54%
on 04/01/25
-0.5600 (-32.94%)
since 03/28/25

Most Recent Stories

More News
OPKO Health to Participate in the Jefferies Biotech on the Beach Summit

MIAMI, Feb. 27, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Jefferies Biotech on the Beach Summit, being held March 10-11,...

OPK : 1.1300 (+2.73%)
OPKO Health: Q4 Earnings Snapshot

OPKO Health: Q4 Earnings Snapshot

OPK : 1.1300 (+2.73%)
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results

MIAMI, Feb. 26, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three and 12 months ended December 31, 2025, and introduces...

OPK : 1.1300 (+2.73%)
OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26

MIAMI, Feb. 12, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and 12 months ended December 31, 2025, after the close of the...

OPK : 1.1300 (+2.73%)
OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism

This is the third  program that s uccessfully combine s Entera’s oral peptide N- Tab ® platform with OPKO ’s advanced protein chemistry capabilities The c ompanies have...

OPK : 1.1300 (+2.73%)
ENTX : 1.0850 (+8.50%)
OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference

MIAMI, Jan. 06, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK ) announced today that management will be participating in the 44 th Annual J.P. Morgan Healthcare Conference, being held January...

OPK : 1.1300 (+2.73%)
OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference

MIAMI, Nov. 19, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Piper Sandler 37 th Annual Healthcare Conference, being held December...

OPK : 1.1300 (+2.73%)
NextPlat Reports Third Quarter 2025 Results

Company Reports $13.8M in Q3 Revenue as Refocusing and Cost Cutting Initiatives Drive Improved Late Quarter Performance with Accelerated Sequential Improvements Expected in Q4 and into 2026 

BABA : 124.52 (+2.08%)
NXPL : 0.3474 (-26.24%)
NXPLW : 0.0240 (-33.33%)
OPK : 1.1300 (+2.73%)
OPKO Health: Q3 Earnings Snapshot

OPKO Health: Q3 Earnings Snapshot

OPK : 1.1300 (+2.73%)
OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results

MIAMI, Oct. 29, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three and nine months ended September 30, 2025. Highlights...

OPK : 1.1300 (+2.73%)

Business Summary

OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and...

See More

Key Turning Points

3rd Resistance Point 1.1567
2nd Resistance Point 1.1433
1st Resistance Point 1.1217
Last Price 1.1300
1st Support Level 1.0867
2nd Support Level 1.0733
3rd Support Level 1.0517

See More

52-Week High 1.6900
Fibonacci 61.8% 1.4627
Fibonacci 50% 1.3925
Fibonacci 38.2% 1.3223
Last Price 1.1300
52-Week Low 1.0950

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.